'Indian pharma industry capable of discovering new drugs'

Last Updated: Saturday, August 29, 2015, 20:22

Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today

Sun Pharma may file new drug application with USFDA: Shanghvi

Last Updated: Thursday, July 30, 2015, 20:47

India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.

Sun Pharma asks some Ranbaxy employees to leave, post merger

Last Updated: Thursday, June 18, 2015, 16:36

Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its USD 4 billion acquisition of the Gurgaon-based firm.

Sun Pharma asks 18 top brass of Ranbaxy to resign

Last Updated: Thursday, June 18, 2015, 12:23

This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.

Open to acquisitions but selective with targets: Sun Pharma

Last Updated: Sunday, May 31, 2015, 12:30

"We continue to remain opportunistic for acquisition... We are not looking at buying businesses where we have to spend a lot of time in managing," Sun Pharma MD Dilip Shanghvi said in an analyst call.

CCI approves Shanghvi's deal with Suzlon

Last Updated: Friday, May 8, 2015, 21:18

Competition Commission has cleared billionaire Dilip Shanghvi's proposed Rs 1,800-crore stake buy in wind turbine maker Suzlon Energy.

Mukesh Ambani regains richest Indian slot from Dilip Shanghvi

Last Updated: Monday, April 27, 2015, 17:05

Industrialist Mukesh Ambani Monday regained his position as the world's richest Indian with a networth of USD 19.6 billion, as pharma tycoon Dilip Shanghvi slipped to the second place after remaining on the top for about seven weeks.

Sun Pharma, Ranbaxy rise after regulatory nods for merger deal

Last Updated: Tuesday, March 24, 2015, 17:33

At the end of today's trade, Sun Pharmaceutical Industries ended at Rs 1,039.85, up 1.55 percent and Ranbaxy Laboratories closed at Rs 819.55 apiece, up 1.86 percent.

Ranbaxy merger: Sun Pharma readies new leadership team

Last Updated: Thursday, March 12, 2015, 15:10

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the organisations.

Ambani loses India rich list top spot to pharma tycoon

Last Updated: Thursday, March 5, 2015, 13:44

A fall in oil prices saw Mukesh Ambani cede his status as "India`s richest man" on Thursday to pharmaceutical tycoon Dilip Shanghvi, who edged to the top of Forbes` list of billionaires in the country.

Dilip Shanghvi overtakes Mukesh Ambani as richest Indian

Last Updated: Wednesday, March 4, 2015, 20:40

Pharma tycoon Dilip Shanghvi Wednesday surpassed Mukesh Ambani as the world's richest Indian with a net worth of USD 21.5 billion -- within two days of Reliance Industries chief being ranked India's wealthiest for 8th year.

Suzlon surges 17%; adds Rs 2,603 cr in m-cap in two days

Last Updated: Wednesday, February 18, 2015, 21:20

Shares of wind turbine maker Suzlon Energy Wednesday surged nearly 17 percent in view of definitive pacts with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore in the company.